This study was conducted to compare the degree of glycemic control, tolerability, and the existence of dysglycemic events whether (hypo and/or hyperglycemia) from the use of either human premixed insulin or basal plus short-acting insulin regimens during treating patients with T2DM who intend to fast Ramadan. This evidence concerns the gene INS and type 2 diabetes mellitus.